Invitae Logo
US46185L1035
A14NKG
0JDB.L

Invitae

Loading quotes...

Forecast

The analysts' average price target is +8,37 (+57.228,77%). The median is +8,59 (+58.735,62%).

Buy
  4
Hold
  6
Sell
  5

  • Labcorp raises full-year outlook and focuses on hospital partnerships

    Labcorp raised its full-year revenue growth forecast to 7.5–8.6% and expects about 8% growth in its diagnostics business, roughly half organic and half inorganic. The acquisition of Invitae is expected to strengthen the second half and boost the unit’s revenue by about 10%; the deal is seen as slightly accretive. The company targets annual cost savings of USD 100–125 million and anticipates margin improvements, but flags regulatory risks such as possible changes to the ACA/Medicaid and an expected PMM-related charge of around USD 100 million. The focus remains on strategic hospital deals, biopharma services and innovations in women's health, oncology, neurology and autoimmune diseases. » More on de.investing.com

Financials

In the last year, Invitae had revenue of +481.32m and net profit of 2.90b
(EUR) 2022
YoY
Revenue +481.32m 18,87%
Gross profit +92.34m 6,07%
Net profit 2.90b 768,85%
EBITDA 2.69b 681,62%

Fundamentals

Metric Value
Market capitalization
+4.67m
Number of shares
286.49m
52-week high/low
+2,01 - +0,0129
Dividends No
Beta
1,59
P/E ratio
0,00
PEG ratio
0,00
P/B ratio
+0,04
P/S ratio
+0,01

Company profile

Invitae Corporation, ein Unternehmen für medizinische Genetik, integriert genetische Informationen in die Schulmedizin, um die Gesundheitsversorgung der Menschen in den Vereinigten Staaten, Kanada und international zu verbessern. Das Unternehmen bietet Gentests in verschiedenen klinischen Bereichen an, darunter erblicher Krebs, Kardiologie, Neurologie, Pädiatrie, Onkologie, Stoffwechselkrankheiten und seltene Krankheiten, digitale Gesundheitslösungen und Gesundheitsdatendienste. Das Unternehmen bedient Patienten, Gesundheitsdienstleister, Biopharmaunternehmen und andere Partner. Das Unternehmen war früher als Locus Development, Inc. bekannt und änderte 2012 seinen Namen in Invitae Corporation. Die Invitae Corporation wurde 2010 gegründet und hat ihren Hauptsitz in San Francisco, Kalifornien.

Name
Invitae
CEO
Kenneth D. Knight
Headquarters San Francisco, ca
USA
Website
Sector
Health Care
Industry
Biotechnology
IPO
02/12/2015
Employees 1.700

Ticker symbols

Exchange Symbol
London Stock Exchange
0JDB.L
NYSE
NVTA
London
0JDB.L
🍪

Parqet  uses cookies. Learn more